Pfizer to sell all its drugs in LICs at non-profit price

Pfizer said yesterday it will offer its full portfolio of drugs, including off-patent medicines such as chemotherapies and oral cancer treatments, on a not-for-profit basis to 45 Low-Income Countries (LICs) in the world.

In an expansion of the company’s “An Accord for a Healthier World” programme, which is aimed at increasing access to innovative treatments in some of the world’s poorest countries, Pfizer said it will now offer a total of 500 products.

When the drugmaker launched the programme in May 2022, it offered only its patented medicines including COVID-19 treatment Paxlovid and its big-selling breast cancer drug, Ibrance, at a not-for-profit price.

Edits by EP News Bureau